EE15: Economic Burden of Transfusion-Dependent Beta-Thalassemia in the United States

EE48: Cost-Effectiveness of Alternative Diagnostic Testing Pathways with Whole Exome Sequencing (WES) in a Rare Disease Patient Population: The Canadian Care-for-Rare SOLVE (SOLVE) Multi-Centre Observational Cohort

EE500: Comparison of Healthcare Resource Utilization and Costs in Patients with and without Bullous Pemphigoid: A Retrospective Analysis of US Health Insurance Claims Data

HSD67: The Burden of Systemic Glucocorticoid (GC) Use in Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis Patients

HSD85: Real-World Usage Patterns and Costs of IVIG Treatment in Adults with Generalized Myasthenia Gravis in the United States

PCR102: Leveraging Social Media for Patient Experience Insights in Rare Disease